These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Synaptic pathology, altered gene expression, and degeneration in photoreceptors impacted by drusen. Johnson PT, Brown MN, Pulliam BC, Anderson DH, Johnson LV. Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4788-95. PubMed ID: 16303980 [Abstract] [Full Text] [Related]
23. Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Johnson LV, Forest DL, Banna CD, Radeke CM, Maloney MA, Hu J, Spencer CN, Walker AM, Tsie MS, Bok D, Radeke MJ, Anderson DH. Proc Natl Acad Sci U S A; 2011 Nov 08; 108(45):18277-82. PubMed ID: 21969589 [Abstract] [Full Text] [Related]
24. Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration. Leu ST, Batni S, Radeke MJ, Johnson LV, Anderson DH, Clegg DO. Exp Eye Res; 2002 Jan 08; 74(1):141-54. PubMed ID: 11878827 [Abstract] [Full Text] [Related]
26. Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: Another mechanism of complement activation in age-related macular degeneration. Wang J, Ohno-Matsui K, Yoshida T, Shimada N, Ichinose S, Sato T, Mochizuki M, Morita I. J Cell Physiol; 2009 Jul 08; 220(1):119-28. PubMed ID: 19277984 [Abstract] [Full Text] [Related]
29. Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis. Iannaccone A, Giorgianni F, New DD, Hollingsworth TJ, Umfress A, Alhatem AH, Neeli I, Lenchik NI, Jennings BJ, Calzada JI, Satterfield S, Mathews D, Diaz RI, Harris T, Johnson KC, Charles S, Kritchevsky SB, Gerling IC, Beranova-Giorgianni S, Radic MZ, Health ABC study. PLoS One; 2015 Jul 08; 10(12):e0145323. PubMed ID: 26717306 [Abstract] [Full Text] [Related]
30. Age related macular degeneration and drusen: neuroinflammation in the retina. Buschini E, Piras A, Nuzzi R, Vercelli A. Prog Neurobiol; 2011 Sep 15; 95(1):14-25. PubMed ID: 21740956 [Abstract] [Full Text] [Related]
35. Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV. Exp Eye Res; 2004 Feb 15; 78(2):243-56. PubMed ID: 14729357 [Abstract] [Full Text] [Related]
37. Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Tuo J, Bojanowski CM, Zhou M, Shen D, Ross RJ, Rosenberg KI, Cameron DJ, Yin C, Kowalak JA, Zhuang Z, Zhang K, Chan CC. Invest Ophthalmol Vis Sci; 2007 Aug 15; 48(8):3827-36. PubMed ID: 17652758 [Abstract] [Full Text] [Related]
38. Identification of anti-retinal antibodies in patients with age-related macular degeneration. Morohoshi K, Ohbayashi M, Patel N, Chong V, Bird AC, Ono SJ. Exp Mol Pathol; 2012 Oct 15; 93(2):193-9. PubMed ID: 22465421 [Abstract] [Full Text] [Related]
39. Immunological factors in the pathogenesis and treatment of age-related macular degeneration. Kijlstra A, La Heij E, Hendrikse F. Ocul Immunol Inflamm; 2005 Feb 15; 13(1):3-11. PubMed ID: 15804763 [Abstract] [Full Text] [Related]
40. Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States. Grus FH, Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Wax MB. Invest Ophthalmol Vis Sci; 2006 Mar 15; 47(3):968-76. PubMed ID: 16505031 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]